Nigeria’s pharmaceutical manufacturers have delivered their strongest earnings in at least a decade, signalling a sharp reversal from years of margin squeeze buoyed by currency volatility and steep import dependence.
Drug manufacturers listed on the Nigerian Exchange Limited more than doubled t
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```